SHA:600276 Market Cap

SHA:600276 has a market cap or net worth of 381.14 billion as of February 3, 2026. Its market cap has increased by 36.11% in one year.

Market Cap

381.14B

Enterprise Value

341.28B

Revenue

30.98B

Ranking

n/a

PE Ratio

49.53

Stock Price

56.56

Market Cap Chart

Since October 20, 2000, SHA:600276's market cap has increased from 2.58B to 381.14B, an increase of 14,692.67%. That is a compound annual growth rate of 21.83%.

Market Cap History

Date	Market Cap	% Change
Feb 3, 2026	381.17B	-3.69%
Dec 31, 2025	395.76B	35.60%
Dec 31, 2024	291.86B	1.48%
Dec 29, 2023	287.60B	17.03%
Dec 30, 2022	245.74B	-23.94%
Dec 31, 2021	323.08B	-45.40%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sichuan Biokin Pharmaceutical	111.35B
Yunnan Baiyao Group Co.,Ltd	99.04B
Zhejiang NHU Company	80.26B
Shanghai Fosun Pharmaceutical (Group)	64.65B
Huadong Medicine	62.80B
Shenzhen Salubris Pharmaceuticals	50.87B
China Resources Sanjiu Medical & Pharmaceutical	46.76B
Beijing Tongrentang	41.31B

Market Cap Rankings